← All stories
Earnings
Why are investors reassessing Smith and Nephew this week after its guidance reset and finance chief exit?
Highlights Revenue ambition for the current year has been trimmed while trading profit moved higher Orthopaedics and advanced wound bioactives were singled out as the softer areas A change in the finance seat has arrived at a delicate stage…
Covered by 1 outlet
All coverage · 1 article